“…As they are genetically unique to each patient, tissue organoid has provided alternative ways of preclinical drug testing and are now being used for the development of “personalized medicine” for several diseases. Organoids have been effectively generated and their application has been demonstrated in various fields, including drug screening, disease modeling, tissue transplant, pathogenesis, and regenerative medicine (Ashok et al, 2020; Parihar, Ferdous Sonia, et al, 2022; Parihar, Puranik, et al, 2022; Parihar, Sonia, et al, 2022; Parihar, Zafar, et al, 2022). In vitro models are more reproducible, permitting a larger sample size to be evaluated on multiple models in a smaller duration of time.…”